✦ LIBER ✦

A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma

✍ Scribed by Kwan H. Chi; Wing K. Chan; Dennis L. Cooper; Sang H. Yen; Ching Z. Lin; Kuang Y. Chen

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 561 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940115)73:2<247::aid-cncr2820730203>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient weekly 24-hour infusional adj

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma

✍ Jin-Ching Lin; Jian-Sheng Jan; Kuang Y. Chen; Chen-Yi Hsu; Wen-Miin Liang; Wen-Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract ## Background. Distant metastasis rather than locoregional recurrence is the major site of failure after adequate radiotherapy in nasopharyngeal carcinoma (NPC). The aim of this study is to evaluate the toxicity and survival of outpatient weekly 24‐hour infusion adjuvant chemotherapy f

A phase II study of continuous infusion

A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma

✍ Jean L. Grem; Nanette McAtee; Frank Balis; Robert Murphy; David Venzon; Barnett 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

A concurrent chemoirradiation with cispl

A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma

✍ Daniel T.T. Chua; Jonathan S. T. Sham; Gordon K. H. Au 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract ## Background. To evaluate the toxicity and efficacy of concurrent chemoirradiation with cisplatin followed by adjuvant ifosfamide, 5‐fluorouracil and leucovorin in patients with stage IVb nasopharyngeal carcinoma (NPC) ## Patients and Methods. Between October 1998 and August 2001, 3

Phase II trial of 5-fluorouracil, leucov

Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma

✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons

Phase II study of oral eniluracil, 5-flu

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

✍ Neal J. Meropol; Donna Niedzwiecki; Donna Hollis; Richard L. Schilsky; Robert J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 3 views

A phase II trial of methotrexate, cispla

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

✍ William K. Oh; Judith Manola; Jerome P. Richie; Kevin R. Loughlin; Philip W. Kan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma. ## METHODS. Twenty-four patients